Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on developing ...

The company will begin with five potential treatments for autoimmune diseases in-licensed from Bristol Myers Squibb, which ...

Luxury goods companies were spared their worst case scenario in Sunday's EU-U.S. trade deal but they face a delicate ...

Bristol Myers Squibb and Bain Capital launch a new biopharma firm focused on autoimmune disease treatments, starting with 5 ...

The most successful carve-out acquisitions start with due diligence that identifies both the carve-out-specific elements and ...

The French prime minister said that the trade deal was an act of quote submission and described it as a dark day for Europe. And a former EU trade official actually, who used to be very high up in the ...

Bain Capital and Bristol Myers Squibb have formed a new biopharmaceutical company focused on developing new therapies for autoimmune diseases. The newly formed company launches with a $300 million ...

Bain Capital's Bridge Data Centres (Bridge DC) has broken ground on a facility in Thailand. Located south of Bangkok in the ...

Luxury’s long boom is over. As the global market corrects, Hermès, Rolex and Cartier thrive. while LVMH, Gucci and Swatch ...

Bank of England governor Andrew Bailey and UK chancellor Rachel Reeves are at odds, and EU politicians are grumbling over the bloc’s trade deal with the US. Plus, the US economy is defying ...

Shareholders in Wise, a rare U.K. tech success, voted in favor of moving its main stock listing to New York and extending dual-class shares by a decade. The company will begin with five potential ...